Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Janku

Showing results (81-90 of 277) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignanciesJohn W Moroney, Matthew P Schlumbrecht, Thorunn Helgason, et al.
Plos One|August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancersFilip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesSiqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
Journal of Computer Assisted Tomography|December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver TumorsPayel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Oncotarget|May 7, 2015
Epithelial to mesenchymal transition is associated with rapamycin resistanceAshley M Holder, Argun Akcakanat, Farrell Adkins, et al.
Oncotarget|November 27, 2014
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experienceMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2016
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancerRabih Said, Eugenia Kakadiaris, Sarina Piha-Paul, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Pageof 28

Showing results (81-90 of 277) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2011
A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignanciesJohn W Moroney, Matthew P Schlumbrecht, Thorunn Helgason, et al.
Plos One|August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancersFilip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2016
Erratum to: Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesSiqing Fu, Kirk S Culotta, Gerald S Falchook, et al.
Journal of Computer Assisted Tomography|December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver TumorsPayel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Oncotarget|May 7, 2015
Epithelial to mesenchymal transition is associated with rapamycin resistanceAshley M Holder, Argun Akcakanat, Farrell Adkins, et al.
Oncotarget|November 27, 2014
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experienceMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2016
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancerRabih Said, Eugenia Kakadiaris, Sarina Piha-Paul, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
Pageof 28